New segment model on human lung cancer
We are thrilled to launch our new model of Non-Small Cell Lung Cancer. We use patient-derived xenografts as well as mouse allografts to replicate clinical
Let’s discuss how we can accelerate your preclinical phase!
Save time
Save time by collecting data at each step of your experiment.
Reduce costs
High-throughput approaches and capacity to follow up single animals.
Real-time visuals
Follow the disease progression in real time from day 0.
In vivo imaging plays a pivotal role in monitoring individual variations in real-time to design safer and more effective therapies.
Explore how our advanced in vivo imaging technology can enhance your capabilities.
+100 completed projects
+20 years of experience
+10 global partners
Several international scientific publications
Discover our cutting-edge segment models, meticulously crafted at our company to unlock the power of drug development and ensure rigorous and efficient preclinical testing for safer and to deliver more effective treatments.
We are thrilled to launch our new model of Non-Small Cell Lung Cancer. We use patient-derived xenografts as well as mouse allografts to replicate clinical
We proudly announce that IVRS AB has been appointed to Industry Winner 2024 within Biotechnical Research and Development! Branschvinnare i Sverige AB awards this title
We continue growing!
Do you want to learn more about our work and how we can help you?
Visit us